Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity

Size: px
Start display at page:

Download "Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity"

Transcription

1 Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity and Sinuses Squamous carcinoma Verrucous carcinoma Squamous cell carcinoma spindle cell Papillary squamous cell carcinoma Basaloid carcinoma Adenosquamous carcinoma Squamous cell carcinoma, adenoid Basaloid squamous cell carcinoma Spindle cell carcinoma Lymphoepithelial carcinoma of the Nasal Cavity and Sinuses Undifferentiated carcinoma of the Nasal Cavity and Sinuses Intestinal type adenocarcinoma the Nasal Cavity and Sinuses EPITHELIAL TUMOURS OF THE NASOPHARYNX Squamous cell carcinoma and variants of the Nasopharynx Squamous carcinoma Squamous cell carcinoma nonkeratinizing, NOS Squamous cell carcinoma keratinizing, NOS Papillary squamous cell carcinoma Basaloid squamous cell carcinoma Squamous cell carcinoma, adenoid Lymphoepithelial carcinoma Undifferentiated carcinoma Papillary adenocarcinoma of the Nasopharynx EPITHELIAL TUMOURS OF THE MAJOR SALIVARY GLANDS and SALIVARY-GLAND TYPE TUMOURS Epithelial tumours of major salivary glands Squamous carcinoma Large cell carcinoma Lymphoepithelial carcinoma

2 3 Carcinosarcoma, NOS Adenocarcinoma NOS Clear cell adenocarcinoma, NOS Mucinous adenocarcinoma Ductal carcinoma Oxyphilic adenocarcinoma Papillary cystadenocarcinoma, NOS Adenoid cystic carcinoma Mucoepidermoid carcinoma Acinic cell adenocarcinoma Malignant myoepithelioma Carcinoma in pleomorphic adenoma Polymorphous low grade adenocarcinoma Basal cell adenocarcinoma Epithelial-myoepithelial carcinoma Sebaceous adenocarcinoma Cystadenocarcinoma, NOS Low grade cribriform cystadenocarcinoma Salivary gland type tumours of the Head and Neck Mucoepidermoid carcinoma Adenocarcinoma NOS Adenoid cystic carcinoma Acinic cell adenocarcinoma Ductal carcinoma Mucinous adenocarcinoma Basal cell adenocarcinoma Clear cell adenocarcinoma, NOS Epithelial-myoepithelial carcinoma Polymorphous low grade adenocarcinoma Carcinoma in pleomorphic adenoma Malignant myoepithelioma Cystadenocarcinoma, NOS Oncocytic carcinoma Myoepithelial carcinoma Papillary cystadenocarcinoma, NOS EPITHELIAL TUMOURS OF THE HYPOPHARYNX AND LARYNX Squamous cell carcinoma and variants of the Hypopharynx Squamous carcinoma Lymphoepithelial carcinoma

3 3 Verrucous carcinoma Squamous cell carcinoma spindle cell Giant cell carcinoma Basaloid carcinoma Adenosquamous carcinoma Squamous cell carcinoma, adenoid Undifferentiated carcinoma Papillary squamous cell carcinoma Basaloid squamous cell carcinoma Squamous cell carcinoma and variants of the Larynx Squamous carcinoma Verrucous carcinoma Squamous cell carcinoma spindle cell Papillary squamous cell carcinoma Adenosquamous carcinoma Basaloid carcinoma Squamous cell carcinoma, adenoid Undifferentiated carcinoma Lymphoepithelial carcinoma Giant cell carcinoma Basaloid squamous cell carcinoma EPITHELIAL TUMOURS OF THE OROPHARYNX Squamous cell carcinoma and variants of the Oropharynx Squamous carcinoma Lymphoepithelial carcinoma Verrucous carcinoma Squamous cell carcinoma spindle cell Papillary squamous cell carcinoma Basaloid carcinoma Squamous cell carcinoma, adenoid Basaloid squamous cell carcinoma Adenosquamous carcinoma Undifferentiated carcinoma EPITHELIAL TUMOURS OF THE ORAL CAVITY and LIP Squamous cell carcinoma and variants of the Oral cavity Squamous carcinoma Verrucous carcinoma Squamous cell carcinoma spindle cell

4 3 Adenosquamous carcinoma Papillary squamous cell carcinoma Basaloid carcinoma Squamous cell carcinoma, adenoid Basaloid squamous cell carcinoma Lymphoepithelial carcinoma Undifferentiated carcinoma Squamous cell carcinoma and variants of the Lip Squamous carcinoma EPITHELIAL TUMOURS OF THE OESOPHAGUS Squamous cell carcinoma and variants of the Oesophagus Squamous carcinoma Adenosquamous carcinoma Squamous cell carcinoma spindle cell Basaloid carcinoma Verrucous carcinoma Papillary squamous cell carcinoma Basaloid squamous cell carcinoma Squamous cell carcinoma, adenoid Adenocarcinoma and variants of the Oesophagus Salivary gland type tumours of the Oesophagus Mucoepidermoid carcinoma Adenoid cystic carcinoma Undifferentiated carcinoma of the Oesophagus EPITHELIAL TUMOURS OF THE STOMACH Adenocarcinoma and variants of the Stomach Adenocarcinoma NOS Adenocarcinoma intestinal type Signet ring cell carcinoma Carcinoma diffuse type Mucinous adenocarcinoma Tubular adenocarcinoma Papillary adenocarcinoma, NOS Adenosquamous carcinoma Squamous cell carcinoma and variants of the Stomach Squamous carcinoma Squamous cell carcinoma spindle cell Basaloid carcinoma 0 1 4

5 3 Verrucous carcinoma Squamous cell carcinoma, adenoid Papillary squamous cell carcinoma Salivary gland type tumours of the Stomach Mucoepidermoid carcinoma Adenoid cystic carcinoma Undifferentiated carcinoma of the Stomach EPITHELIAL TUMOURS OF THE SMALL INTESTINE Adenocarcinoma and variants of the Small Intestine Adenocarcinoma NOS Mucinous adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Medullary carcinoma, NOS Undifferentiated carcinoma Squamous cell carcinoma and variants of the Small Intestine Squamous carcinoma EPITHELIAL TUMOURS OF THE COLON Adenocarcinoma and variants of the Colon Adenocarcinoma NOS Mucinous adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Undifferentiated carcinoma Medullary carcinoma, NOS Squamous cell carcinoma and variants of the Colon EPITHELIAL TUMOURS OF THE RECTUM Adenocarcinoma and variants of the Rectum Adenocarcinoma NOS Mucinous adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Undifferentiated carcinoma Medullary carcinoma, NOS Squamous cell carcinoma and variants of the Rectum Verrucous carcinoma Basaloid carcinoma of the Rectum

6 1 EPITHELIAL TUMORS OF THE ANAL CANAL Squamous cell carcinoma and variants of the Anal Canal Verrucous carcinoma Undifferentiated carcinoma Adenocarcinoma and variants of the Anal Canal Mucinous adenocarcinoma Basaloid carcinoma of the Anal Canal Paget disease of the Anal Canal EPITHELIAL TUMOURS OF THE PANCREAS Adenocarcinoma and variants of the Pancreas Adenocarcinoma NOS Mucinous adenocarcinoma Undifferentiated carcinoma Signet ring cell carcinoma Adenosquamous carcinoma Squamous cell carcinoma and variants of the Pancreas Acinar cell carcinoma of the Pancreas Mucinous cystadenocarcinoma of the Pancreas Intraductal papillary mucinous carcinoma invasive of the Pancreas Solid pseudopapillary carcinoma of the Pancreas Serous cystadenocarcinoma of the Pancreas Carcinoma with osteoclast-like giant cells of the Pancreas EPITHELIAL TUMOURS OF THE LIVER and INTRAEPATIC BILE TRACT (IBT) Hepatocellular carcinoma of the Liver and IBT Combined hepatocellular carcinoma and cholangiocarcinoma Hepatocellular carcinoma, fibrolamellar Cholangiocarcinoma of the IBT Adenocarcinoma and variants of the Liver and IBT Undifferentiated carcinoma of the Liver and IBT Squamous cell carcinoma and variants of the Liver and IBT Bile duct cystadenocarcinoma of the IBT EPITHELIAL TUMOURS OF THE GALLBLADDER and EXTRAHEPATIC BILIARY TRACT (EBT) Adenocarcinoma and variants of the Gallbladder and EBT Cholangiocarcinoma Papillary adenocarcinoma, NOS

7 3 Adenocarcinoma intestinal type Mucinous adenocarcinoma Clear cell adenocarcinoma, NOS Signet ring cell carcinoma Adenosquamous carcinoma Undifferentiated carcinoma Bile duct cystadenocarcinoma Combined hepatocellular carcinoma and cholangiocarcinoma of the Gallbladderand EBT Squamous cell carcinoma of the Gallbladder and EBT EPITHELIAL TUMOUR OF THE TRACHEA Squamous cell carcinoma and variants of the Trachea Squamous carcinoma Papillary squamous cell carcinoma Basaloid squamous cell carcinoma Squamous cell carcinoma clear cell type Verrucous carcinoma Squamous cell carcinoma, adenoid Spindle cell carcinoma Adenosquamous carcinoma Lymphoepithelial carcinoma Giant cell carcinoma Undifferentiated carcinoma Adenocarcinoma and variants of the Trachea Adenocarcinoma NOS Mucinous adenocarcinoma Papillary adenocarcinoma, NOS Solid carcinoma, NOS Clear cell adenocarcinoma, NOS Acinic cell adenocarcinoma Signet ring cell carcinoma Mucinous cystadenocarcinoma, NOS Salivary gland type tumours of the Trachea Adenoid cystic carcinoma Mucoepidermoid carcinoma Myoepithelial carcinoma EPITHELIAL TUMOUR OF THE LUNG Squamous cell carcinoma and variants of the Lung Squamous carcinoma

8 3 Papillary squamous cell carcinoma Basaloid squamous cell carcinoma Squamous cell carcinoma small cell nonkeratinizing Squamous cell carcinoma clear cell type Adenocarcinoma and variants of the Lung Adenocarcinoma NOS Mucinous adenocarcinoma Papillary adenocarcinoma, NOS Solid carcinoma, NOS Clear cell adenocarcinoma, NOS Acinic cell adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Mucinous cystadenocarcinoma, NOS Adenocarcinoma with mixed subtypes Fetal adenocarcinoma Large cell carcinoma of the Lung Poorly differentiated endocrine carcinoma of the Lung Small cell endocrine carcinoma of the Lung Large cell endocrine carcinoma of the Lung Bronchiolo-alveolar carcinoma of the Lung Bronchiolo-alveolar carcinoma, mucinous Bronchiolo-alveolar carcinoma, non mucinous Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous Salivary gland type tumours of the Lung Adenoid cystic carcinoma Mucoepidermoid carcinoma Myoepithelial carcinoma Sarcomatoid carcinoma of the Lung Sarcomatoid carcinoma Pleomorphic carcinoma Giant cell carcinoma Carcinosarcoma, NOS Spindle cell carcinoma Undifferentiated carcinoma of the Lung EPITHELIAL TUMOURS OF THE THYMUS Malignant tymoma Thymoma, malignant, NOS

9 3 Malignant thymoma, type AB Malignant thymoma, type A Malignant thymoma, type B Malignant thymoma, type C Squamous cell carcinoma of the Thymus Undifferentiated carcinoma of the Thymus Lymphoepithelial carcinoma of the Thymus Adenocarcinoma and variants of the Thymus Adenocarcinoma NOS Papillary adenocarcinoma, NOS EPITHELIAL TUMOURS OF THE BREAST Invasive ductal carcinoma of the Breast Invasive lobular carcinoma of the Breast Classic type Pleomorphic carcinoma Mammary Paget s disease of the Breast Special types of adenocarcinoma of the Breast Tubular adenocarcinoma Mucinous carcinoma Medullary carcinoma, NOS Papillary adenocarcinoma, NOS Cribriform carcinoma Apocrine adenocarcinoma Secretory carcinoma Glycogen-rich clear cell carcinoma Lipid-rich carcinoma Oncocytic carcinoma Metaplastic carcinoma of the Breast Squamous carcinoma Adenosquamous carcinoma Adenocarcinoma with cartilaginous and osseous metaplasia Adenocarcinoma with spindle cell metaplasia Salivary gland type tumours of the Breast Mucoepidermoid carcinoma Adenoid cystic carcinoma Myoepithelial carcinoma Acinic cell adenocarcinoma

10 2 Epithelial tumour of the Male Breast EPITHELIAL TUMOURS OF THE CORPUS UTERI Adenocarcinoma and variants of the Corpus Uteri Adenocarcinoma NOS Endometrioid adenocarcinoma, NOS Adenosquamous carcinoma Clear cell adenocarcinoma, NOS Serous cystadenocarcinoma, NOS Mucinous adenocarcinoma Mixed cell adenocarcinoma Endometrioid adenocarcinoma secretory variant Villous adenocarcinoma Endometrioid adenocarcinoma ciliated cell variant Squamous cell carcinoma and variants of the Corpus Uteri Adenoid cystic carcinoma of the Corpus Uteri Transitional cell carcinoma of the Corpus Uteri EPITHELIAL TUMOURS OF THE CERVIX UTERI Squamous cell carcinoma and variants of the Cervix Uteri Squamous carcinoma Squamous cell carcinoma nonkeratinizing, NOS Squamous cell carcinoma keratinizing, NOS Papillary squamous cell carcinoma Papillary carcinoma, NOS Verrucous/Warty carcinoma Basaloid carcinoma Squamous cell carcinoma spindle cell Lymphoepithelial carcinoma Transitional cell carcinoma, NOS Glassy cell carcinoma Adenocarcinoma and variants of the Cervix Uteri Adenocarcinoma NOS Adenocarcinoma with squamous metaplasia Mucinous adenocarcinoma Clear cell adenocarcinoma, NOS Endometrioid adenocarcinoma, NOS Serous cystadenocarcinoma, NOS Signet ring cell carcinoma Mesonephroma malignant

11 3 Villous adenocarcinoma Mucinous adenocarcinoma, endocervical type Adenocarcinoma intestinal type Mixed cell adenocarcinoma Undifferentiated carcinoma of the Cervix Uteri EPITHELIAL TUMOURS OF THE OVARY and FALLOPIAN TUBE Adenocarcinoma and variants of the Ovary Serous cystadenocarcinoma, NOS Adenocarcinoma NOS Endometrioid adenocarcinoma, NOS Papillary adenocarcinoma, NOS Serous surface papillary carcinoma Endometrioid adenofibroma malignant Clear cell adenocarcinofibroma Serous adenocarcinofibroma Mucinous adenocarcinofibroma Mucinous adenocarcinoma of the Ovary Clear cell adenocarcinomaof the Ovary Adenocarcinoma and variants of the Fallopian tube Adenocarcinoma NOS Papillary serous cystadenocarcinoma Serous cystadenocarcinoma, NOS Papillary adenocarcinoma, NOS NON EPITHELIAL TUMOURS OF THE OVARY Mixed epithelial/mesenchymal tumors of the Ovary Mullerian mixed tumor Adenosarcoma Sex cord tumors of the Ovary Granulosa cell tumor malignant Sertoli-Leydig cell tumor poorly differentiated Steroid cell tumor, malignant Malignant/Immature Teratomas of the Ovary Teratoma, malignant, NOS Struma ovarii, malignant Primitive neuroectodermal tumor, NOS Ependymoma Medulloepithelioma, NOS

12 3 Glioblastoma Sebaceous adenocarcinoma Germ cell tumor of the Ovary Dysgerminoma/Seminoma Yolk sac tumor Mixed germ cell tumor Embryonal adenocarcinoma Choriocarcinoma, NOS Polyembryoma EPITHELIAL TUMOURS OF THE VULVA & VAGINA Squamous cell carcinoma and variants of the Vagina and Vulva Adenocarcinoma and variant of the Vagina and Vulva Paget disease Vagina and Vulva Undifferentiated carcinoma Vagina and Vulva TROPHOBLASTIC TUMOUR OF THE PLACENTA Choriocarcinoma of the Placenta EPITELIAL TUMOURS OF THE PROSTATE Adenocarcinoma and variants of the Prostate Adenocarcinoma NOS Acinic cell adenocarcinoma Mucinous adenocarcinoma Signet ring cell carcinoma Adenocarcinoma with neuroendocrine differentiation Oxyphilic adenocarcinoma Spindle cell carcinoma Lymphoepithelial carcinoma Squamous cell carcinoma and variants of the Prostate Squamous carcinoma Adenosquamous carcinoma Infiltrating duct carcinoma of the Prostate Cribriform carcinoma Solid carcinoma, NOS Papillary adenocarcinoma, NOS Transitional cell carcinoma of the Prostate Salivary gland type tumours of the Prostate Adenoid cystic carcinoma Basaloid carcinoma

13 3 Basal cell adenocarcinoma TUMOURS OF THE TESTIS and PARATESTIS Adenocarcinoma and variants of the paratestis Endometrioid adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Serous cystadenocarcinoma, NOS Mucinous cystadenocarcinoma, NOS Collecting duct and rete testis carcinoma Transitional cell carcinoma, NOS Malignant/Immature Teratomas of the Testis Mixed germ cell tumor Teratocarcinoma Choriocarcinoma combined with other germ cell elements Teratoma with malignant transformation Germ cell tumor Seminomatous of the Testis Seminoma, NOS Spermatocytic seminoma Germ cell tumor non Seminomatous of the Testis Embryonal adenocarcinoma, NOS Yolk sac tumor Trophoblastic Tumours of the Testis Choriocarcinoma, NOS Sex Cord Tumours of the Testis Leydig cell tumor malignant Sertoli cell carcinoma Malignant sex cord/gonadal stromal tumors EPITHELIAL TUMOURS OF THE PENIS Squamous cell carcinoma and variants of the Penis Squamous carcinoma Verrocous carcinoma Squamous cell carcinoma, sarcomatoid Adenosquamous carcinoma Basaloid carcinoma Adenocarcinoma and variants of the Penis Extramammary Paget disease Sebaceous adenocarcinoma Papillary adenocarcinoma, NOS

14 3 Mixed tumor malignant, NOS Clear cell adenocarcinoma, NOS Basal cell adenocarcinoma EPITELIAL TUMOURS OF THE KIDNEY Renal cell carcinoma and variants Adenocarcinoma NOS Renal cell adenocarcinoma Clear cell adenocarcinoma, NOS Papillary adenocarcinoma, NOS Renal cell carcinoma chromophobe type Collecting duct carcinoma Xp translocation carcinoma Carcinoma associated with neuroblastoma Renal medullary carcinoma Mucinous tubular and spindle cell carcinoma Squamous cell carcinoma spindle cell type of the Kidney Squamous cell carcinoma and variants of the Kidney EPITHELIAL TUMOURS OF THE PELVIS, URETHER and URETHRA Transitional cell carcinoma of the Pelvis, Ureter and Urethra Undifferentiated carcinoma Transitional cell carcinoma spindle cell Lymphoepithelioma-like carcinoma Transitional cell carcinoma, giant cell Transitional cell carcinoma, micropapillary Squamous cell carcinoma and variants of the Pelvis, Ureter and Urethra Verrucous carcinoma Adenocarcinoma and variants of the Pelvis, Ureter and Urethra Mucinous adenocarcinoma Clear cell adenocarcinoma, NOS Signet ring cell carcinoma Salivary gland-type tumours of the Pelvis, Ureter and Urethra Basaloid carcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma EPITHELIAL TUMOURS OF THE BLADDER Transitional cell carcinoma of the Bladder Undifferentiated carcinoma

15 3 Transitional cell carcinoma spindle cell Transitional cell carcinoma with squamous differentiation Lymphoepithelial carcinoma Giant cell carcinoma Transitional cell carcinoma micropapillary Squamous cell carcinoma and variants of the Bladder Verrucous carcinoma Adenocarcinoma and variants of the Bladder Mucinous adenocarcinoma Clear cell adenocarcinoma, NOS Signet ring cell carcinoma Salivary gland type tumours of the Bladder Basaloid carcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma EPITHELIAL TUMOURS OF THE EYE and ADNEXA Squamous cell carcinoma and variants of the Eye and Adnexa Squamous carcinoma Basal cell carcinoma Adenocarcinoma and variants of the Eye and Adnexa Adenocarcinoma NOS Adenoid cystic carcinoma Mucoepidermoid carcinoma EPITHELIAL TUMOURS OF THE MIDDLE EAR Squamous cell carcinoma and variants the Middle Ear Squamous carcinoma Adenocarcinoma and variants the Middle Ear Adenocarcinoma NOS Adenoid cystic carcinoma MALIGNANT MESOTHELIOMA Mesothelioma of the pleura and pericardium Epithelioid malignant mesothelioma Sarcomatoid malignant mesothelioma Mesothelioma of the peritoneum and tunica vaginalis Epithelioid malignant mesothelioma Sarcomatoid malignant mesothelioma

16 1 MALIGNANT SKIN MELANOMA Superficial spreading melanoma Nodular melanoma Lentigo maligna melanoma Acral lentiginous melanoma malignant MALIGNANT MELANOMA OF THE MUCOSA MALIGNANT MELANOMA OF THE UVEA EPITHELIAL TUMOURS OF THE SKIN Basal cell carcinoma of the Skin Basal cell carcinoma NOS Basosquamous carcinoma Multifocal superficial basal cell carcinoma Basal cell carcinoma nodular Basal cell carcinoma fibroepithelial Adenoid basal carcinoma Squamous cell carcinoma and variants of the Skin Squamous carcinoma Verrucous carcinoma Spindle cell carcinoma Pseudo vascular/ Squamous cell carcinoma adenoid Adenosquamous carcinoma ADNEXAL CARCINOMA OF THE SKIN Nodular hidradenoma, malignant Sebaceous adenocarcinoma Adenoid cystic carcinoma Paget disease extramammary Apocrine adenocarcinoma Mucinous adenocarcinoma Pilomatrix carcinoma Eccrine poroma, malignant Mixed tumor malignant, NOS Sclerosing sweat duct carcinoma Malignant eccrine spiradenoma Tubular adenocarcinoma Eccrine papillary adenocarcinoma EXTRAGONADIC EMBRYONAL NEOPLASMS Neuroblastoma and ganglioneuboblastoma

17 2 Nephroblastoma Retinoblastoma Hepatoblastoma Pulmonary blastoma Pancreatoblastoma EXTRAGONADIC GERM CELL TUMOURS Extragonadic malignant/immature Teratomas Teratoma malignant Mixed germ cell tumor Teratocarcinoma Choriocarcinoma combined with other germ cell elements Extragonadic Germ cell tumor Dysgerminoma/Seminoma Embryonal adenocarcinoma Yolk sac tumor Choriocarcinoma, NOS Polyembryoma SOFT TISSUE SARCOMA Soft tissue sarcoma of the Head and Neck Sarcoma NOS Epithelioid sarcoma Desmoplastic small round cell tumour Fibrosarcoma Fibromyxosarcoma Infantile fibrosarcoma Myxoinflammatory fibroblastic sarcoma Malignant fibrous histiocytoma DFSP Well differentiated liposarcoma Myxoid liposarcoma Pleomorphic liposarcoma Mixed type liposarcoma Dedifferentiated liposarcoma Leiomyosarcoma Pleomorphic rhabdomyosarcoma Extrarenal rhabdoid tumour Synovial sarcoma

18 3 Clear cell sarcoma of soft tissue Epithelioid angiosarcoma Epithelioid hemangioendothelioma Extraskeletal osteosarcoma Extraskeletal myxoid chondrosarcoma Malignant peripheral nerve sheath tumours Intimal Sarcoma Low grade fibromyxoid sarcoma Low grade myofibroblastic sarcoma PEComas Sclerosing epithelioid fibrosarcoma Undifferentiated pleomorphic sarcoma Soft tissue sarcoma of the Limbs * Soft tissue sarcoma of the Superficial Trunk * Soft tissue sarcoma of the Mediastinum * Soft tissue sarcoma of the Heart * Soft tissue sarcoma of the Breast * Soft tissue sarcoma of the Uterus * Soft tissue sarcoma of the Genitourinary (other) * Soft tissue sarcoma of the other Viscera * Soft tissue sarcoma of the Paratesticular region * Soft tissue sarcoma of the Retroperitoneum and Peritoneum * Soft tissue sarcoma of the Pelvis * Soft tissue sarcoma of the Skin * Soft tissue sarcoma of the Paraorbital region * Soft tissue sarcoma of the Brain and other Nervous System * * includes all the entities listed for the soft tissue of the Head and Neck 2 Embryonal rhabdomyosarcoma of the Soft Tissue Alveolar rhabdomyosarcoma of the Soft Tissue Ewing s family tumours of the Soft Tissue BONE SARCOMA Osteogenic sarcoma Conventional osteosarcoma Teleangectatic osteosarcoma Small cell osteosarcoma Paraosteal osteosarcoma

19 3 High grade surface osteosarcoma Low grade central osteosarcoma Periosteal osteosarcoma Secondary osteosarcoma Chondrogenic sarcomas Chondrosarcoma Mesenchymal chondrosarcoma Clear cell chondrosarcoma Dedifferentiated chondrosarcoma Notochordal sarcomas, Chordoma Chordoma Vascular sarcomas, Angiosarcoma Angiosarcoma Ewing s family of tumours Ewing s sarcoma/pnet Epithelial tumours, Adamantinoma Adamantinoma Other high grade sarcomas (fibrosarcoma, malignant fibrous histyocitoma) Fibrosarcoma Malignant fibrous histyocitoma GASTROINTESTINAL STROMAL SARCOMA KAPOSI SARCOMA NEUROENDOCRINE CARCINOMAS Well differentiated endocrine tumours, carcinoid Well differentiated endocrine tumours, atypical carcinoid Poorly differentiated endocrine carcinoma (lung excluded) Small cell endocrine carcinoma Large cell endocrine carcinoma Mixed endocrine-exocrine carcinoma Endocrine carcinoma of Thyroid gland Medullary carcinoma, NOS Mixed medullary-follicular carcinoma Well differentiated endocrine carcinoma, not functioning of Pancreas and Digestive tract Carcinoid tumor, NOS Islet cell carcinoma Well differentiated endocrine carcinoma, functioning of Pancreas and Digestive tract

20 3 Insulinoma, malignant Glucagonoma, malignant Somatostatinoma, malignant Gastrinoma, malignant VIP-oma Other ectopic hormone producing tumours Endocrine carcinoma of Skin Merkel cell carcinoma CARCINOMA OF ENDOCRINE ORGANS Carcinomas of Pituitary gland Pituitary carcinoma, NOS Carcinomas of Thyroid gland Papillary adenocarcinoma, NOS follicular carcinoma, NOS Pleomorphic carcinoma Undifferentiated/anaplastic carcinoma Mucoepidermoid carcinoma Mucinous carcinoma Spindle cell tumour with thymous-like differentiation (SETTLE) Carcinoma showing thymus-like differentiation (CASTLE) Carcinomas of Parathyroid gland Parathyroid carcinoma Carcinoma of adrenal gland Adrenal cortical carcinoma GLIAL TUMOURS OF THE CNS and PINEAL GLAND Astrocytic tumors of the CNS Astrocytoma, NOS Astrocytoma, anaplastic Glioblastoma Gliosarcoma Giant cell glioblastoma Astroblastoma Protoplasmic astrocytoma Gliomatosis cerebri Pleomorphic xanthoastrocytoma Pilocytic and Pilomixoid astrocytoma Oligoastrocytoma

21 3 Subependymal giant cell astrocytoma Oligodendroglial tumors of the CNS Oligodendroglioma Oligodendroglioma, anaplastic Ependymal tumors of the CNS Ependymoma, NOS Ependymoma, anaplastic Subependymoma Myxopapillary ependymoma NON GLIAL TUMOURS OF THE CNS and PINEAL GLAND Embryonal tumours of the CNS Medulloblastoma Desmoplastic nodular medulloblastoma PNET Anaplastic ganglioglioma Atypical teratoid/rhabdoid tumor Medulloepithelioma, NOS Large cell and anaplastic medulloblastoma Pineoblastoma Choroid plexus carcinoma of the CNS MALIGNANT MENINGIOMAS GLIAL TUMOURS OF THE NERVES, AUTONOMIC NERVOUS SYSTEM and PARAGANGLIA Astrocytic tumors of the Nerves, Autonomic Nervous System and Paraganglia Astrocytoma, NOS Astrocytoma anaplastic Glioblastoma Gliosarcoma Ganglioglioma, anaplastic Ependymal tumors of the the Nerves, Autonomic Nervous System and Paraganglia Ependymoma, NOS NON-GLIAL TUMOURS OF THE NERVES, AUTONOMIC NERVOUS SYSTEM and PARAGANGLIA Embryonal tumours of the Nerves, Autonomic Nervous System and Paraganglia PNET Olfactory neuroblastoma Olfactory neuroepithelioma Olfactory neurogenic tumor Teratoid medulloepithelioma

22 3 Neuroepithelioma, NOS LYMPHOID DISEASES Classical Hodgkin Lymphoma lymphocyte-rich mixed cellularity lymphocyte-depleted nodular sclerosis Hodgkin lymphoma nodular lymphocyte predominance Composite Hodgkin/NHL Precursor B/T lymphoblastic leukaemia/lymphoblastic lymphoma Non Hodgkin Mature T cell and NK-cell neoplasms T cutaneous lymphoma (Sezary syn, Mycosis fung) Other T cell lymphomas Non Hodgkin, Mature B cell lymphoma Small cell lymphocytic lymph/chronic lymphatic leukaemia Mantle cell/lymph centrocytic Prolymphocytic leukaemia, B cell Lymphoplasmacitic/Waldenström macroglobulinemia Burkitt leukaemia/lymphoma Diffuse B lymphoma Splenic/nodal marginal zone/extra nodal MALT type Follicular B lymphoma Hairy cell leukaemia Plasmocitoma/multiple mieloma Heavy chain disease ACUTE MYELOYD LEUKAEMIA AND RELATED PRECURSOR NEOPLASMS Acute Myeloid Leukemia (AML) with recurrent genetic abnormalities AML with t(8;21)(q22;q22); AML 1/ETO) AML with inv(16)(p13.1q22)or t( 16; 16)(p13.1q22),(CBFbeta/MYH ) Acute promyelocytic leukemia (AML with t(15;17) and variants Acute myeloid leukemia 11q23 abnormalities Acute myeloid leukemia NOS (FAB or WHO type not specified) AML with myelodysplasia-related changes and RAEBT-T AML with myelodisplasia-related changes Refractory Anemia with excess blasts in trasformation (RAEBT-T) Therapy-related myeloid neoplasms Therapy related myelodysplastic syndrome NOS

23 3 Therapy-related myeloid neoplasms Acute Myeloid Leukamia no categorized and other AML Acute myeloid leukemia minimally differentiation Acute myeloid leukemia without maturation Acute myeloid leukemia with maturation Acute myelomonocytic leukemia Acute myeloid leukemia MVI type Acute monoblastic and monocytic leukemia Acute erytroid leukemia Acute basophilic leukemia Acute megakaryoblastic leukemia Acute panmyelosis with myelofibrosis Acute leukemias with ambiguous lineage Myeloid sarcoma Blastic plasmocytoid dendritic cell neoplasm MYELOPROLIFERATIVE NEOPLASMS Chronic myeloid leukemia Chronic myeloid leukemia NOS Chronic myelogenous leukemia BCRABL positive Myelosclerosis with myeloid metaplasia Essential thrombocythemia Polycythemia vera Myeloproliferative diseases, others Chronic myeloproliferative disease NOS Chronic neutrophilic leukemia Hypereosinophilic syndrome MYELODYSPLASTIC SYNDROME Refractory anemia Refractory anemia with sideroblasts Refractory anemia with excess blasts Refractory cytopenia with multilineage dysplasia Myelodysplastic syndrome with Vq syndrome Myelodysplastic syndrome NOS MYELOSDYSPLASTIC/MYELOPROLIFERATIVE DISEASES Chronic myelomonocytic leukemia NOS Juvenile myelomonocytic leukemia Atypical chronic myeloid leukemia BCRABL negative

24 1 MAST CELL TUMOURS Mastocytoma NOS/mast cell sarcoma Malignant mastocytosis Mast cell leukaemia HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS Histiocytic sarcoma Langherans cell histiocytosis Langherans cell sarcoma Interdigitating dendritic cell sarcoma Follicular dendritic cell sarcoma Fibroblastic reticular cell tumour

ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31

ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31 R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,

More information

incidence rate x 100,000/year

incidence rate x 100,000/year Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European

More information

Rare cancers are those with an incidence rate 6/100,000

Rare cancers are those with an incidence rate 6/100,000 Rare cancers are those with an incidence rate 6/100,000 Layer Tumour Rate x 100,000 Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.44 3,594 2 Squamous cell carcinoma and variants of the

More information

Methoden / Methods inc. ICCC-3 105

Methoden / Methods inc. ICCC-3 105 Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International

More information

ANNUAL CANCER REGISTRY REPORT-2015

ANNUAL CANCER REGISTRY REPORT-2015 CANCER STATISTICS Distribution of neoplasms ANNUAL CANCER REGISTRY REPORT-2015 Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Hina Asif, Adna Atif, Farhana Badar Of a total of 5,924 new neoplasms diagnosed

More information

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3

More information

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)

More information

2018 ICD-O-3 Updates in Table Format with Annotation for Reference

2018 ICD-O-3 Updates in Table Format with Annotation for Reference Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine

More information

ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN

ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Lubna Nadeem,

More information

ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN

ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Mehwish Waseem,

More information

2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:

2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at:  Tel: Fax: E-Path A.I. Engine Knowledge Base Enhancements Version 1.0.0.29 April 1, 2018 The major enhancements in the E-Path Knowledge Base from versions 1.0.0.28 through 1.0.0.29 are as follows: 1. Addition/modification

More information

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind

More information

S2199 S2200. * Speaker's diagnosis 78

S2199 S2200. * Speaker's diagnosis 78 98 21 2 14 13:30 * Speaker's diagnosis 78 S2199 Meningioma 48 Papillary meningioma * 30 Angiomatous meningioma 15 Ependymoma 12 Papillary ependymoma 6 Anaplastic ependymoma 2 Cellular ependymoma 1 Hemangioblastoma

More information

SHN-1 Human Digestive Panel Test results

SHN-1 Human Digestive Panel Test results SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3

More information

Chapter 4. Histological groups

Chapter 4. Histological groups Chapter 4. Histological groups D.M. Parkin, J. Ferlay, K. Shanmugaratnam, L. Sobin, L. Teppo and S.L. Whelan In this volume, the main axis of classification is provided by the predominantly site-based

More information

CODING TUMOUR MORPHOLOGY. Otto Visser

CODING TUMOUR MORPHOLOGY. Otto Visser CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded

More information

CANCER REGISTRY 2002

CANCER REGISTRY 2002 2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not

More information

CANCER REGISTRY 2004

CANCER REGISTRY 2004 2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office

More information

Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1

Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1 MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the

More information

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes Acute basophilic leukemia 9870/3 Acute biphenotypic leukemia [OBS] 9805/3 Acute erythroid leukemia 9840/3 Acute megakaryoblastic leukemia 9910/3 Acute monoblastic and monocytic leukemia 9891/3 Acute myeloid

More information

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes Malignant lymphoma, NOS 9590/3 Non-Hodgkin lymphoma, NOS 9591/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma 9596/3 Primary

More information

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant

More information

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic

More information

ANNUAL CANCER REGISTRY REPORT-2005

ANNUAL CANCER REGISTRY REPORT-2005 ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males

More information

RARECARENet country report Bulgaria

RARECARENet country report Bulgaria RARECARENet country report Bulgaria 26 April 2016 Contents 1. Introduction... 3 2. The epidemiology of rare cancers in Bulgaria... 4 3. Quality indicators for centres of expertise for rare cancers... 5

More information

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation Major subgroups according to the World Health Organisation (WHO) Classification Myeloproliferative neoplasms (MPN) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or

More information

Radiation Oncology Study Guide

Radiation Oncology Study Guide Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire

More information

CLIC Sargent Eligibility Criteria

CLIC Sargent Eligibility Criteria 1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd

More information

Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.

Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15. SUPPLEMENTARY MATERIALS Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.0) Basket preferred term 5q minus

More information

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group)

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) January 2013 The NCIN is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving

More information

Cancer in Estonia 2014

Cancer in Estonia 2014 Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Table 1 trials currently open for patients with pheochromocytoma and/or paraganglima (from trials.gov) www.clinicaltrials.gov; Active PPGL trials Status Of Sunitinib In Patients With Recurrent

More information

The European Commission s science and knowledge service. Joint Research Centre

The European Commission s science and knowledge service. Joint Research Centre The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What

More information

Supplementary Information

Supplementary Information Rise in Glioblastoma Multiforme incidence in England 1995 2015 suggests an adverse environmental or lifestyle factor Alasdair Philips, Denis L Henshaw, Graham Lamburn, Michael J O Carroll Supplementary

More information

Appendix 4: WHO Classification of Tumours of the pancreas 17

Appendix 4: WHO Classification of Tumours of the pancreas 17 S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:

More information

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival

More information

Diagnostic IHC in lung and pleura pathology

Diagnostic IHC in lung and pleura pathology Diagnostic IHC in lung and pleura pathology Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark WHO 2004 and Web Malignant mesothelioma Epithelioid

More information

Comprehensive Cancer Cover

Comprehensive Cancer Cover Comprehensive Cancer Cover Tech Spec Comprehensive Cancer Cover provides the life insured with cover for the diagnosis and treatment of defined malignant tumours. These tumours must be characterised either

More information

International Agency for Research on Cancer. World Health Organization International Association of Cancer Registries

International Agency for Research on Cancer. World Health Organization International Association of Cancer Registries International Agency for Research on Cancer World Health Organization International Association of Cancer Registries I A R C I A C R CHECK AND CONVERSION PROGRAMS FOR CANCER REGISTRIES (IARC/IACR Tools

More information

Table of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3

Table of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3 Table of Contents Preface xi Acknowledgments xiii Part I Overview of the Diagnostic Process 1 1 Overview of Grading and Staging 3 Identification of the process 3 Identification of tumor types 5 Grading

More information

ACR TXIT TM EXAM OUTLINE

ACR TXIT TM EXAM OUTLINE ACR TXIT TM EXAM OUTLINE Major Domain Sub-Domain 1 Statistics 1.1 Study design 1.2 Definitions of statistical terms 1.3 General interpretation & analysis 1.4 Survival curves 1.5 Specificity/sensitivity

More information

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and

More information

2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING

2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING 2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Eight Groups are Revised for 2018 Head & Neck Colon (includes rectosigmoid and rectum for cases diagnosed 1/1/2018 forward) Lung (2018 Draft not yet

More information

Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER

Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January

More information

Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS

Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS Multiple Primary and Histology Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways

More information

Oncology Centre Research Unit TUMOR REGISTRY

Oncology Centre Research Unit TUMOR REGISTRY 1 Oncology Centre Research Unit TUMOR REGISTRY ANNUAL REPORT 2013 1 Annual Report Prepared by the Staff of the Tumor Registry Research Unit, Oncology Centre King Faisal Specialist Hospital and Research

More information

Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults

Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository (2007 09) for cancer in Teenagers and Young Adults (TYA) CTYA SSCRG Data quality report on the frequency

More information

S Y M P O S I U M P R O G R A M

S Y M P O S I U M P R O G R A M Dear colleagues, dear friends We would like to cordially welcome you to the 10 th International Arkadi M. Rywlin International Pathology Slide Seminar in Anatomic Pathology to be held in Split, Croatia.

More information

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients

More information

Differential Diagnosis of Oral Masses. Palatal Lesions

Differential Diagnosis of Oral Masses. Palatal Lesions Differential Diagnosis of Oral Masses Palatal Lesions Palatal Masses Periapical Abscess Torus Palatinus Mucocele Lymphoid Hyperplasia Adenomatous Hyperplasia Benign Salivary Neoplasms Malignant Salivary

More information

Quiz The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d.

Quiz The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d. 1. The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d. All of the above Quiz 1 2. Which part of the broad ligament suspends the ovaries? a.

More information

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional

More information

2007 Multiple Primary and

2007 Multiple Primary and 2007 Multiple Primary and Histology Coding Rules Beyond the Basics Florida Cancer Data System Annual Conference Tampa, FL July 26,2007 Steven Peace, CTR Westat Carol Johnson, CTR NCI SEER Peggy Adamo,

More information

Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018)

Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Please refer to your standard setter(s) for specific reporting requirements before using

More information

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Soft Tissue Sarcoma, Neuroendocrine Tumors (NET) and Gastrointestinal Stromal Tumors (GIST) Agenda Updates Soft Tissue Sarcoma Overview CSv2 MP/H

More information

S2 File. Clinical Classifications Software (CCS). The CCS is a

S2 File. Clinical Classifications Software (CCS). The CCS is a S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous

More information

* Speaker's diagnosis

* Speaker's diagnosis * Speaker's diagnosis Creutzfeldt-Jacob disease(cjd) 5 Prion disease( Creutzfeldt-Jakob disease ) 3 Extrapontine myelinolytis 5 Subacute sclerosing panencephalitis (SSPE) 5 Central pontine myelinolysis

More information

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care. Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and

More information

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology Contents Part I Introduction 1 General Description... 3 1.1 Introduction... 3 1.2 Incidence and Prevalence... 5 1.3 Predisposing and Genetic Factors... 8 References... 16 2 Natural History: Importance

More information

Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact

Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact Dermatitis Psoriasis Lichen Simplex Chronicus Foreign Body

More information

Human cell line list Production of Exosome Standards - Cell Lysates

Human cell line list Production of Exosome Standards - Cell Lysates Human cell line list 2016 - Production of Exosome Standards - Cell Lysates 380 peripheral blood leukemia, pre-b cell 1301 blood leukemia, acute lymphoblastic, T cell 5637 bladder carcinoma 8305C thyroid

More information

Pathology Mystery and Surprise

Pathology Mystery and Surprise Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor

More information

National Cancer Intelligence Network Rare and less common cancers. Incidence and Mortality in England, 2010 to 2013

National Cancer Intelligence Network Rare and less common cancers. Incidence and Mortality in England, 2010 to 2013 National Cancer Intelligence Network Rare and less common cancers Incidence and Mortality in England, 2010 to 2013 About Public Health England Public Health England exists to protect and improve the nation's

More information

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005 ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy

More information

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018 1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington

More information

FINALIZED SEER SINQ QUESTIONS

FINALIZED SEER SINQ QUESTIONS 0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as

More information

Detailed Table of Contents

Detailed Table of Contents Detailed 1 Immunostains: Introduction... 1 Natasha Rekhtman and Justin Bishop General Background... 1 Applications of Immunohistochemistry in Anatomic Pathology... 1 Markers of Differentiation at a Glance...

More information

Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version (downloaded 3/23/2017)

Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version (downloaded 3/23/2017) APPENDIX I. SEER Search criteria and exclusion criteria. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version 8.3.4 (downloaded 3/23/2017) SEER*Stat Database:

More information

List of Available TMAs in the PRN

List of Available TMAs in the PRN TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2

More information

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

More information

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC # DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #2006-01 CATEGORY: CLARIFICATION SUBJECT: RESCINDMENT - DSQC MEMORANDUM 2002-08 Coding Complex Morphologic Diagnoses (revised 8/02) EFFECTIVE: For Cases

More information

Salivary Glands 3/7/2017

Salivary Glands 3/7/2017 Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.

More information

Tinh hoàn

Tinh hoàn Tinh hoàn Tinh hoàn Tinh hoàn Tiền liệt tuyến Tiền liệt tuyến Mào tinh hoàn Mào tinh hoàn Túi tinh Túi tinh Túi tinh Túi tinh So-called cystadenoma of seminal vesicle. Gross appearance of granulomatous

More information

S2326. Paucicellular myxoid liposarcoma 1 Histiocytic sarcoma 1 Alveolar soft part sarcoma 1 Perivascular epithelioid cell tumor (PEComa) 1

S2326. Paucicellular myxoid liposarcoma 1 Histiocytic sarcoma 1 Alveolar soft part sarcoma 1 Perivascular epithelioid cell tumor (PEComa) 1 S2325 Encephalitis 21 Encephalitis 4 Cerebritis 1 Meningoencephalitis 4 Acute disseminated encephalomyelitis 2 Acute encephalitis(virus) 1 Herpes simplex encephalitis* 2 Encephalitis, viral infection?

More information

RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI

RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI RARE TUMOURS OF THE FEMALE GENITAL SYSTEM 17% OF FEMALE GENITAL SYSTEM TUMOURS ARE RARE 3 093 553 RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI 6 7 % OF RARE TUMOURS OUT OF

More information

Clinical Coding for CRS Standards

Clinical Coding for CRS Standards Clinical Coding for CRS Standards The following appendices set out the amended PRIMARY DIAGNOSIS coding structure to be used for the monitoring of cancer waiting times following the implementation of 4th

More information

Pathology of the female genital tract

Pathology of the female genital tract Pathology of the female genital tract Common illnesses of the female genital tract Before menarche Developmental anomalies Tumors (ovarial teratoma) Amenorrhea Fertile years PCOS, ovarian cysts Endometriosis

More information

RAMATHIBODI CANCER REPORT

RAMATHIBODI CANCER REPORT RAMATHIBODI CANCER REPORT 2016 Ramathibodi Cancer Registry : A subsidiary of Ramathibodi Comprehensive Cancer Center Faculty of Medicine, Ramathibodi Hospital Mahidol University Table of content INTRODUCTION...III

More information

The International Classification of Diseases for Oncology (ICD-O) is

The International Classification of Diseases for Oncology (ICD-O) is 1425 COMMENTARY Classification Schemes for Tumors Diagnosed in Adolescents and Young Adults Ronald D. Barr, M.B., Ch.B., M.D. 1 3 Eric J. Holowaty, M.D., M.Sc. 4 Jillian M. Birch, B.Sc., M.Sc., Ph.D. 5

More information

Cancer survival in Shanghai, China,

Cancer survival in Shanghai, China, Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely

More information

13-24 year olds with cancer in England Incidence, mortality and survival

13-24 year olds with cancer in England Incidence, mortality and survival 13-24 year olds with cancer in England Incidence, mortality and survival National Cancer Registration and Analysis Service in collaboration with Teenage Cancer Trust About Public Health England Public

More information

Childhood cancer registration in England: 2015 to 2016

Childhood cancer registration in England: 2015 to 2016 Childhood cancer registration in England: 2015 to 2016 Report on behalf of the Children, Teenagers and Young Adults Site Specific Clinical Reference Group, National Cancer Registration and Analysis Service

More information

Florida Cancer Data System STAT File Documentation Version 2019

Florida Cancer Data System STAT File Documentation Version 2019 Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status

More information

Grade Coding Instructions and Tables

Grade Coding Instructions and Tables Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth

More information

Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2 on all newly diagnosed cases

Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2 on all newly diagnosed cases Adrenal cortical carcinoma Inhibin Synap Melan-A Calretinin Vimentin Chromogr CK7 CK20 Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2

More information

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies Web appendix 2: SEARCH STRATEGIES Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies MEDLINE 1. exp epidemiologic studies/

More information

Surveys and Anatomic Pathology Education Programs

Surveys and Anatomic Pathology Education Programs Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-B 2018 Participant Summary 2018 College of American Pathologists. The College does not permit

More information

Lesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009

Lesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009 Diagnostic Problems in Salivary Gland Pathology An Update Lesions Mimicking Adenoid Cystic Carcinoma Stacey E. Mills, M.D. W.S. Royster Professor of Pathology Director of Surgical and Cytopathology University

More information

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung 82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea

More information

Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse. March, 2000

Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse. March, 2000 Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse March, 2000 Information Prepared by Mary L. A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D. CHARLES RIVER LABORATORIES TABLE OF CONTENTS

More information

E. Staging a WHO (World Health Organization) b TNM (Tumor Node Metastasis)

E. Staging a WHO (World Health Organization) b TNM (Tumor Node Metastasis) I KNOWLEDGE LIST ONCOLOGY Knowledge of neoplasms in animals (dog, cat, pocket pets, horses, cows) A. Clinical signs, History, Physical Exam (PE) B. Work up 1. Diagnostic Imaging a Bone Scan b Thyroid Scan

More information

Minimally invasive adenocarcinoma. 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS)

Minimally invasive adenocarcinoma. 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS) Minimally invasive adenocarcinoma 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS) 2b lepidic acinar 2c papillary micropapillary solid 2d cribriform

More information

Anatomic Pathology Study Sets Glass Slides

Anatomic Pathology Study Sets Glass Slides Anatomic Pathology Study Sets Glass Slides California Tumor Tissue Registry 11021 Campus Street, AH335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu Web Site: www.cttr.org

More information

Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases

Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Peiguo G. Chu, M.D., Ph.D., Lawrence M. Weiss, M.D. Department of Pathology, City of Hope National Medical Center,

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information